Impact and effectiveness of 13-valent pneumococcal conjugate vaccine on population incidence of vaccine and non-vaccine serotype invasive pneumococcal disease in Blantyre, Malawi, 2006–18: prospective observational time-series and case-control studies

BACKGROUND: The population impact of pneumococcal conjugate vaccines (PCVs) depends on direct and indirect protection. Following Malawi's introduction of the 13-valent PCV (PCV13) in 2011, we examined its impact on vaccine and non-vaccine serotype invasive pneumococcal disease among vaccine-eli...

Descripción completa

Detalles Bibliográficos
Autores principales: Bar-Zeev, Naor, Swarthout, Todd D, Everett, Dean B, Alaerts, Maaike, Msefula, Jacquline, Brown, Comfort, Bilima, Sithembile, Mallewa, Jane, King, Carina, von Gottberg, Anne, Verani, Jennifer R, Whitney, Cynthia G, Mwansambo, Charles, Gordon, Stephen B, Cunliffe, Nigel A, French, Neil, Heyderman, Robert S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8220129/
https://www.ncbi.nlm.nih.gov/pubmed/34143997
http://dx.doi.org/10.1016/S2214-109X(21)00165-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8220129/
https://www.ncbi.nlm.nih.gov/pubmed/34143997
http://dx.doi.org/10.1016/S2214-109X(21)00165-0

Ejemplares similares